Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026)
Beta Bionics (BBNX) posted Return on Capital Employed of 30.48% for Q2 2026, down 15.66% sequentially from 26.35% in Q1 2026, and down 1060.0% YoY from 3.17% in Q2 2025.
Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026) Analysis & Trends
Beta Bionics has reported Return on Capital Employed for 2 years, with the latest figure at 30.48% in Q2 2026.
- Quarterly Return on Capital Employed fell 1060.0% year-over-year to 30.48% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 30.48% (down 1060.0% YoY) and the FY2025 annual result came in at 34.42%, up 721.0% from the prior year.
- Return on Capital Employed slipped to 30.48% in Q2 2026 per BBNX's latest filing, from 26.35% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 19.88% in Q2 2025 and troughed at 30.48% in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Beta Bionics | 853.71 Mn | 673.22 Mn | 18.90 Mn | -30.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.48% |
| Mar 31, 2026 | -26.35% |
| Dec 31, 2025 | -24.02% |
| Sep 30, 2025 | -22.52% |
| Jun 30, 2025 | -19.88% |
| Mar 31, 2025 | -23.95% |